Prime Medicine (PRME) traded down -1.63 % during a 24 hours period ending at 10:16 AM Central Europe on Tuesday 27th. One Prime Medicine stock can currently be bought for about USD 3.61 on popular exchanges. Current supply of Prime Medicine stocks is 179.6 mn. Prime Medicine has a current market capitalization of USD 652.9 mn and approximately USD 9.1 mn worth of Prime Medicine was traded on exchanges in the last 24 hours. Since last month end, Prime Medicine has traded 25.57 % up. Simple moving average of last 200 days is at USD 3.48. The highest price of past 52 weeks was recorded at USD 5.02 on 10/31/2025. 52 weeks low was at USD 2.67 on 06/11/2026.
Here is how related stocks have performed in the past 24 hours:
Sprout Social (SPT) traded down -0.78 % and now trades at USD 12.76. Current market capitalisation for Sprout Social is USD 782.3 mn.
John B Sanfilippo & Son (JBSS) traded up 0.46 % and now trades at USD 67.37. Current market capitalisation for John B Sanfilippo & Son is USD 783 mn. John B Sanfilippo & Son has a current price to earnings ratio of 12.71.
Ardelyx (ARDX) traded down -2.6 % and now trades at USD 3. Ardelyx has a market capitalisation of USD 770 mn.
Latham (SWIM) traded up 0.53 % and now trades at USD 6.68. Latham has a market capitalisation of USD 775.2 mn. Current price/earnings ratio for Latham is 145.6.
Varex Imaging (VREX) traded down -0.05 % and now trades at USD 18.41. Current market capitalisation for Varex Imaging is USD 775.9 mn. Current price/earnings ratio for Varex Imaging is 35.4.
About Prime Medicine
Prime Medicine, Inc. is a biotechnology company that specializes in developing a versatile gene editing technology to address the fundamental causes of disease by searching and replacing genes to restore normal genetic function. The company operates globally, serving customers worldwide, and its official website is www.primemedicine.com . Prime Medicine went public on the Nasdaq stock exchange on October 20th, 2022.